Portugal's fourth-largest lender Novo Banco, which is preparing for an initial public offering (IPO), said on Thursday its consolidated net profit hit a record 744.6 million euros ($804 million) in ...

Novo Banco SA, a Portuguese lender that’s majority-owned by Lone Star, said its planned initial public offering could take ...

LISBON (Reuters) - Portugal's fourth-largest lender Novo Banco, which is preparing for an initial public offering (IPO), said ...

As Heart Month reminds us of the critical need to protect our cardiovascular and metabolic (CVM) health, Novo Nordisk Philippines and the Philippine College of Endocrinology, Diabetes, and ...

Investing.com -- Novo Nordisk shares climbed more than 3% premarket on Tuesday after Hims&Hers Health announced it may no longer sell compounded versions of semaglutide, the active ingredient in ...

More Bonds of Banco Espírito Santo S.A. [Luxembourg Branch] Moody’s Daily Credit Risk Score About the Banco Espírito Santo S.A. [Luxembourg Branch]-Bond (XS1034421419) The Banco Espírito ...

Revenues in the biopharma industry continued to boom in the fourth quarter of last year, following a pattern seen increasingly throughout 2024. Of the world’s 22 biopharma companies that had ...

In response to the Hims & Hers TV ad, Novo Nordisk — the manufacturer of Ozempic and Wegovy — put out a print ad in the New York Times and USA Today stating, “Do you really know what you ...

The FDA today declared the national deficit of GLP-1 diet drugs at an end. Well, at least for Novo Nordisk's Ozempic and Wegovy. Novo Nordisk sales should be going up, and Hims & Hers Health's ...

All semaglutide doses are now being “continuously shipped” to wholesalers and “meeting or exceeding expected U.S. demand,” Novo Nordisk said in a Friday press release. The company added ...